Comprehensive Financial Consultants Institutional’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.11M Buy
34,411
+1,282
+4% +$107K 0.82% 46
2026
Q1
$2.65M Buy
33,129
+681
+2% +$56.1K 0.79% 44
2025
Q4
$2.77M Buy
32,448
+739
+2% +$60.6K 0.84% 42
2025
Q3
$2.47M Buy
31,709
+1,254
+4% +$98K 0.76% 48
2025
Q2
$2.38M Buy
30,455
+3,523
+13% +$263K 0.78% 45
2025
Q1
$1.95M Buy
26,932
+2,304
+9% +$165K 0.69% 51
2024
Q4
$1.82M Buy
24,628
+1,971
+9% +$138K 0.66% 53
2024
Q3
$1.5M Buy
22,657
+824
+4% +$59.9K 0.55% 70
2024
Q2
$2.02M Buy
21,833
+1,397
+7% +$124K 0.79% 45
2024
Q1
$1.95M Buy
20,436
+1,619
+9% +$136K 0.81% 47
2023
Q4
$1.43M Buy
18,817
+2,555
+16% +$178K 0.67% 63
2023
Q3
$1.13M Buy
16,262
+2,534
+18% +$204K 0.59% 67
2023
Q2
$1.27M Buy
13,728
+935
+7% +$81.3K 0.67% 60
2023
Q1
$1.06M Buy
12,793
+1,000
+8% +$78.6K 0.6% 65
2022
Q4
$917K Buy
11,793
+1,010
+9% +$77.8K 0.55% 69
2022
Q3
$921K Buy
10,783
+419
+4% +$40.3K 0.61% 58
2022
Q2
$998K Buy
10,364
+104
+1% +$10.8K 0.71% 50
2022
Q1
$1.03M Buy
10,260
+797
+8% +$89.4K 0.72% 46
2021
Q4
$1.07M Buy
+9,463
New +$1.1M 0.69% 44

Other funds holding EW

Comprehensive Financial Consultants Institutional's EW Position: Q2 2026 in Review

Comprehensive Financial Consultants Institutional increased its Edwards Lifesciences (EW) stake by 3.9% in Q2 2026, buying an estimated $107K and bringing the position to 34,411 shares worth $3.11M. The position accounts for 0.82% of the portfolio, ranked #46.

Comprehensive Financial Consultants Institutional first reported a position in EW in Q4 2021 and has held it in 19 quarters since. 195 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Comprehensive Financial Consultants Institutional held 34,411 shares of Edwards Lifesciences worth $3.11M as of Q2 2026.
  • Comprehensive Financial Consultants Institutional bought 1,282 Edwards Lifesciences shares in Q2 2026, an estimated $107K.
  • Edwards Lifesciences made up 0.82% of Comprehensive Financial Consultants Institutional's portfolio in Q2 2026, its #46 holding.
  • Comprehensive Financial Consultants Institutional first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • 195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Comprehensive Financial Consultants Institutional's 13F filing for Q2 2026, filed 15 Jul 2026.